West Oak Capital buys $1,648,936 stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : West Oak Capital scooped up 890 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 4, 2016. The investment management firm now holds a total of 21,200 shares of Danaher Corporation which is valued at $1,648,936.Danaher Corporation makes up approximately 1.14% of West Oak Capital’s portfolio.

Other Hedge Funds, Including , Washington Trust Bank reduced its stake in DHR by selling 31 shares or 1.59% in the most recent quarter. The Hedge Fund company now holds 1,919 shares of DHR which is valued at $149,260. Danaher Corporation makes up approx 0.04% of Washington Trust Bank’s portfolio.Cullinan Associates Inc reduced its stake in DHR by selling 19,800 shares or 38.58% in the most recent quarter. The Hedge Fund company now holds 31,525 shares of DHR which is valued at $2,452,015. Danaher Corporation makes up approx 0.21% of Cullinan Associates Inc’s portfolio.Beacon Financial Group reduced its stake in DHR by selling 200 shares or 6.8% in the most recent quarter. The Hedge Fund company now holds 2,740 shares of DHR which is valued at $213,117. Danaher Corporation makes up approx 0.04% of Beacon Financial Group’s portfolio.Lau Associates reduced its stake in DHR by selling 150 shares or 1.31% in the most recent quarter. The Hedge Fund company now holds 11,320 shares of DHR which is valued at $880,470. Danaher Corporation makes up approx 0.90% of Lau Associates’s portfolio.Bath Savings Trust Co reduced its stake in DHR by selling 260 shares or 1.87% in the most recent quarter. The Hedge Fund company now holds 13,663 shares of DHR which is valued at $1,062,708. Danaher Corporation makes up approx 0.34% of Bath Savings Trust Co’s portfolio.

Danaher Corporation closed down -0.33 points or -0.42% at $77.66 with 19,84,522 shares getting traded on Tuesday. Post opening the session at $78.28, the shares hit an intraday low of $77.43 and an intraday high of $78.33 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.